The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, China Health Group's share price is HK$0.176.
China Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.02. Hence, China Health Group's PS Ratio for today is 7.33.
The historical rank and industry rank for China Health Group's PS Ratio or its related term are showing as below:
HKSE:08225'
s PS Ratio Range Over the Past 10 Years
Min: 1.14 Med: 5.38 Max: 65.83
Current: 7.34
During the past 13 years, China Health Group's highest PS Ratio was 65.83. The lowest was 1.14. And the median was 5.38.
HKSE:08225's PS Ratio is ranked worse than 78.04% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.995
vs HKSE:08225: 7.34
China Health Group Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of China Health Group was -29.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -37.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -24.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.60% per year.
During the past 13 years, China Health Group's highest 3-Year average Revenue per Share Growth Rate was 41.60% per year. The lowest was -40.40% per year. And the median was -1.80% per year.
Back to Basics: PS Ratio
China Health Group PS Ratio Historical Data
The historical data trend for China Health Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Health Group's PS Ratio
For the Diagnostics & Research subindustry, China Health Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where China Health Group's PS Ratio falls into.
China Health Group PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
China Health Group's Share Price of today is HK$0.176. China Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
China Health Group (HKSE:08225) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
China Health Group PS Ratio Related Terms
Thank you for viewing the detailed overview of China Health Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's republic of china. The company provides provision of post launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), Drugs technologies, and Other medical services. The majority of the revenue for the company comes from the provision of PM services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:08225 has been successfully added to your 